The analysis of Global Antiinfective Medicine Sales Share by Country in 2024 reveals that the United Kingdom leads with $25.47 million PPP, followed by South Korea's $20.02 million and Spain's $17.74 million. Greece demonstrates notable growth with a 3.17% increase year-on-year, while Japan experiences a decline of 2.99%. Smaller markets like Estonia and Iceland show significant percentage increases, at 7.39% and 10.16% respectively. The CAGR over the past five years reflects varied trends, with positive growth in markets like Greece and Costa Rica and declines in countries including Hungary and Japan.
Future trends to watch in the Global Antiinfective Medicine market include:
- Emerging markets growing at rapid rates such as Estonia and Iceland.
- Potential declines in traditionally large markets like Japan and Hungary.
- Continuing stability and moderate growth in significant markets like the United Kingdom and Spain.
- The impact of innovation and new market entrants on overall sales distribution.
Top countries in Antiinfective Medicine Sales Share by Country (Million US Dollars PPP)
| # | 10 Countries | Percent | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 United Kingdom | 25.47 | 2023 | +2.63% | +2.8% | View data |
| 2 | 2 South Korea | 20.02 | 2023 | +1.36% | -0.33% | View data |
| 3 | 3 Spain | 17.74 | 2023 | +3.45% | +0.88% | View data |
| 4 | 4 Greece | 8.14 | 2023 | +1.9% | +3.17% | View data |
| 5 | 5 Japan | 5.94 | 2023 | -5.06% | -2.99% | View data |
| 6 | 6 Chile | 5.46 | 2023 | +6.46% | +1.41% | View data |
| 7 | 7 Belgium | 5.39 | 2023 | -1.13% | +2.41% | View data |
| 8 | 8 Sweden | 2.68 | 2023 | +14.36% | -1.79% | View data |
| 9 | 9 Denmark | 1.81 | 2023 | +1.77% | +2.04% | View data |
| 10 | 10 Austria | 1.67 | 2023 | +3.48% | -2.04% | View data |
